Jack Khattar – CEO & President at Supernus Pharmaceuticals Inc
Jack Khattar serves as CEO & President for Supernus Pharmaceuticals Inc, as well as on their Board of Directors at Cognition Therapeutics. Since 2012, he has made 22 trades of SUPN stock.
He received his Bachelor of Business Administration from American University of Beirut and Masters of Business Administration from Wharton School at University of Pennsylvania, becoming founder and President of Supernus Pharmaceuticals since 2005.
Early Life and Education
Jack Khattar hails from Lebanon and earned both his Bachelor of Business Administration from American University of Beirut and MBA from Wharton School, University of Pennsylvania. Today, he serves as CEO for Supernus Pharmaceuticals Inc, a biopharmaceutical company which develops and commercializes treatments for central nervous system diseases such as Trokendi XR, Oxtellar XR, Apokyn XADAGO and Myobibloc products.
James has served on the boards of directors of Rockville Economic Development Inc since 2003 and Prevacus Inc, both privately-held companies. At Supernus Pharmaceuticals he is highly esteemed with his CEO score being in the top 20% among comparable-sized companies on Comparably and being particularly popular with Caucasian employees, those over 10 years experience, and female employees.
Jack Khattar serves as Chairman of Cognition Therapeutics Inc. He also holds positions at scPharmaceuticals and Adamas Pharmaceuticals LLC as Chairman, Navitor Pharmaceuticals, Inc. as Board Member and New Rhein Healthcare Investors as Advisor. Jack graduated with his bachelor’s in Marketing from American University Beirut before going on to receive an MBA degree at Wharton School University of Pennsylvania.
He started his YouTube channel as a way of sharing comedy videos with friends, but has quickly become one of the world’s leading social media personalities with over 17 million subscribers and over 3.3 billion video views on his account.
She is well-known for her Let’s Play videos and gaming content on YouTube, Twitch, and Chaturbate as well as her music channel which features her singing and dancing to popular songs.
Achievement and Honors
Beyhadh on Sony TV and Kya Qusoor Hai Amala Ka? on Star Plus were his leading roles. Additionally, he voiced actors such as Tom Hanks, Jack Black, Robert Downey Jr, Dominic West and Nicolas Cage among many others for movie roles. Additionally he is on the Board of Directors at scPharmaceuticals which develops subcutaneous pharmaceutical products; Cognition Therapeutics which develops clinical stage neuroscience drugs targeting degenerative diseases by modulating cell damage response pathways appointed him as Chairman in 2021.
Jack Khattar, CEO & President of Supernus Pharmaceuticals. He is highly rated by employees with an employee feedback score of 9 out of 10, particularly among Caucasian employees and those with more than 10 Years experience.
Jack serves on the boards of directors of Rockville Economic Development Inc and Prevacus, Inc as well as Licensing Executives Society and serves as Chairman for both Cognition Therapeutics and scPharmaceuticals as well as Adamas Pharmaceuticals LLC; additionally he sits on their advisory boards.
Khattar also excels as an accomplished voice artist, dubbing for many Hollywood actors such as Robert Downey Jr., Tom Hanks, Jack Black and Nicolas Cage.
Jack Khattar has served as CEO for six companies, currently holding positions as chairman at Cognition Therapeutics, Inc. and president, chief executive officer, secretary and director at scPharmaceuticals Inc. Additionally he sits on the boards of Adamas Pharmaceuticals LLC and Navitor Pharmaceuticals, Inc. Additionally he held marketing and business development roles at Merck & Co, CIMA Labs Shire Laboratories Novartis Corporation Kodak Ltd in his career history. According to our insider trading data Jack has made 22 trades valued over $35 Million! Get alerted whenever Jack trades SUPN stock buy/sells or vice versa! Sign up now!
*Jack A Khattar earned $8,116,721 as President, Chief Executive Officer, Secretary and Director of Supernus Pharmaceuticals Inc in 2021 – this included $1.757,400 received as Total Cash compensation and $6341,179 awarded through Equity awards.